1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed) is sponsored by NIH Fogarty International Center. This program supports institutions in low- and middle-income countries to strengthen their research administration capacity for global health research. It encourages collaborative applications from U.
S.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Expired PAR-21-037: Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed) This notice has expired. Check the NIH Guide for active opportunities and notices. Department of Health and Human Services Part 1.
Overview Information Participating Organization(s) National Institutes of Health ( NIH ) Components of Participating Organizations National Institute of Allergy and Infectious Diseases ( NIAID ) Funding Opportunity Title Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed) G11 - Extramural Associate Research Development Award (EARDA) September 12, 2023 - This PAR has been reissued as PAR-23-300 NOT-OD-23-012 Reminder: FORMS-H Grant Application Forms and Instructions Must be Used for Due Dates On or After January 25, 2023 - New Grant Application Instructions Now Available September 29, 2022 - Notice of Change to Key Dates and Eligibility Information in PAR-21-037, Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed) .
See Notice NOT-AI-22-065 NOT-OD-22-190 - Adjustments to NIH and AHRQ Grant Application Due Dates Between September 22 and September 30, 2022 October 28, 2021 - Reminder: FORMS-G Grant Application Forms & Instructions Must be Used for Due Dates On or After January 25, 2022 - New Grant Application Instructions Now Available. See Notice NOT-OD-22-018 .
September 13, 2021 - Updates to the Non-Discrimination Legal Requirements for NIH Recipients. See Notice August 5, 2021 - New NIH "FORMS-G" Grant Application Forms and Instructions Coming for Due Dates on or after January 25, 2022. August 5, 2021 - Update: Notification of Upcoming Change in Federal-wide Unique Entity Identifier Requirements.
See Notice NOT-OD-21-170 April 20, 2021 - Expanding Requirement for eRA Commons IDs to All Senior/Key Personnel. See Notice NOT-OD-21-109 Funding Opportunity Announcement (FOA) Number Companion Funding Opportunity See Section III. 3.
Additional Information on Eligibility . Catalog of Federal Domestic Assistance (CFDA) Number(s) Funding Opportunity Purpose The purpose of this Funding Opportunity Announcement (FOA) is to invite applications from research institutions in low- to middle-income countries (LMIC) to provide senior administrators from these institutions with advanced training in the management of NIH grants.
The ultimate goal is to improve oversight of NIAID grant awards and compliance with NIH funding policies and Federal research funding requirements for NIAID-supported foreign institutions in low to middle-income countries.
Open Date (Earliest Submission Date) Letter of Intent Due Date(s) 30 days prior to the application due date July 28, 2021; July 28, 2022; December 5, 2022; July 28, 2023 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. AIDS Application Due Date(s) July 28, 2021; July 28, 2022; December 5, 2022; July 28, 2023 All applications are due by 5:00 PM local time of applicant organization.
All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
December 2021; December 2022; April 2023; December 2023 January 2022; January 2023; May 2023; January 2024 May 2022; May 2023; July 2023; May 2024 Required Application Instructions It is critical that applicants follow the instructions in the Research (R) Instructions in the SF424 (R&R) Application Guide ,except where instructed to do otherwise (in this FOA or in a Notice from NIH Guide for Grants and Contracts .
Conformance to all requirements (both in the Application Guide and the FOA) is required and strictly enforced. Applicants must read and follow all application instructions in the Application Guide as well as any program-specific instructions noted in Section IV . When the program-specific instructions deviate from those in the Application Guide, follow the program-specific instructions.
Applications that do not comply with these instructions may be delayed or not accepted for review. Part 1. Overview Information Part 2.
Full Text of Announcement Section I. Funding Opportunity Description Section II. Award Information Section III.
Eligibility Information Section IV. Application and Submission Information Section V. Application Review Information Section VI.
Award Administration Information Section VII. Agency Contacts Section VIII. Other Information Part 2.
Full Text of Announcement Section I. Funding Opportunity Description Since 1997, the NIH has dramatically increased its funding of research and training in developing countries. To help NIAID foreign research partners successfully manage grants and cooperative agreements, regional post-award grants policies and management training workshops are held twice a year.
NIAID hosts the three-day regional post-award grants management training workshops in countries where there are institutions that receive NIAID research funding. The objective is to help business officials, scientists, and grants managers better understand NIAID/NIH funding policies and DHHS regulations.
While these regional training events have helped many attendees, they are usually too short and the cost of travel is often not affordable to institutions. This Funding Opportunity Announcement (FOA) will enable senior administrators from low- to middle-income countries (LMICs) to receive training in NIH grants policy and financial management of grants, including compliance with NIH scientific reporting requirements.
For this FOA a senior administrator is considered to be institutional staff with responsibility for grants administration including business officials, grants managers and scientists with administrative responsibilities.
The purpose of this FOA is to encourage submission of applications from research institutions in LMICs, as defined by The World Bank , to provide their senior administrators with advanced training in the management of NIH grants.
The overall intent of the initiative is to support the training of senior administrators and empower them to serve as institutional grants management leaders; provide them with access to good business practices for managing awards; assist the administrative staff in developing and implementing standard operating procedures for tracking grant expenditures, complying with NIH funding policies; and assist or train other administrators in the local area.
These opportunities would be provided in the form of grants to "train-the-trainer" by sponsoring grants administration training for senior foreign business officials to receive hands-on training at US institutions. This FOA will provide support for travel of senior administrator(s) from the LMIC institution to a partner US host institution where they will receive hands-on training in grants administration.
These senior administrator(s) are expected to train others at their home institutions and, as needed, implement grants management changes, as well as serve as a resource for training other local or regional institutions receiving NIAID funds. These trained individuals would then train other grants administration officials and improve their local internal business practices.
Up to two senior administrators from the LMIC institution will receive training at a US host institution for up to 1 month during the award period (2 weeks in the first year and 2 weeks in the second year), as well as attend either a NIH regional workshop on program funding and grants administration, or a NIAID post-award grants policy and management training event.
The FOA will also support up to two senior administrators from the LMIC institution for five days of in-house training with the Grants Management Program (GMP) at NIAID in Rockville, MD. This training will allow GMP staff to provide customized information about managing NIAID awards, as well as tailored hands-on training based on the needs of the institutions.
An additional goal of the FOA is to support "sustainability initiatives" for NIH research grants administration. Sustainability initiatives should include activities that facilitate research grants administration activities that would be initiated during the grant funding period with the potential to continue after the funding has ended.
Examples include, but are not limited to, development of standard operating procedures (SOPs) that include specific steps for effectively managing sponsored research funds within the local institution and the development of a new in-house, grants management career track for business management trainees or college students.
The purpose of this element is to enable the PD(s)/PI(s) to initiate a local new or revised grants administration process, and collect relevant data to demonstrate the importance of developing or strengthening grants management activities that can help to maintain institutional competitiveness and/or the efficiency and productivity of research administration operations.
For additional information see NIAID questions and answers webpage for PAR-21-037 https://www. niaid. nih.
gov/grants-contracts/opportunity-specific-questions-and-answers . See Section VIII. Other Information for award authorities and regulations.
Section II. Award Information Grant: A support mechanism providing money, property, or both to an eligible entity to carry out an approved project or activity. Application Types Allowed The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types.
Only those application types listed here are allowed for this FOA. Not Allowed: Only accepting applications that do not propose clinical trials Need help determining whether you are doing a clinical trial? Funds Available and Anticipated Number of Awards The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Application budgets are limited to $100,000 per 18 months in direct costs. Indirect costs for foreign grantees are limited to 8%. The total project period may not exceed 18 months.
NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this FOA. Section III. Eligibility Information Non-domestic (non-U.S.) Entities (Foreign Institutions) Eligible organizations must be in a LMIC, as defined by The World Bank, and include research institutions in LMICs.
Eligible applicant foreign institutions in LMICs are limited to those receiving NIAID grant and/or cooperative agreement funding at the time of application submission. Eligible organizations must have received no more than $8 million in total NIAID grant and/or cooperative agreement support (primary grantee awards) in the last 5 years at the time of application submission.
In order to assure that the US host institutions have appropriate expertise in the management and administration of NIH grants, the applicants' US host institutions are limited to US institutions that, at the time of submission, have received at least $5 million per year in total NIH research grant and/or cooperative agreement support over the last 10 years. Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement , are allowed. Applicant organizations must complete and maintain the following registrations as described in the SF 424 (R&R) Application Guide to be eligible to apply for or receive an award.
All registrations must be completed prior to the application being submitted. Registration can take 6 weeks or more, so applicants should begin the registration process as soon as possible. The NIH Policy on Late Submission of Grant Applications states that failure to complete registrations in advance of a due date is not a valid reason for a late submission.
Dun and Bradstreet Universal Numbering System (DUNS) - All registrations require that applicants be issued a DUNS number. After obtaining a DUNS number, applicants can begin both SAM and eRA Commons registrations. The same DUNS number must be used for all registrations, as well as on the grant application.
System for Award Management (SAM) Applicants must complete and maintain an active registration, which requires renewal at least annually. The renewal process may require as much time as the initial registration. SAM registration includes the assignment of a Commercial and Government Entity (CAGE) Code for domestic organizations which have not already been assigned a CAGE Code.
NATO Commercial and Government Entity (NCAGE) Code Foreign organizations must obtain an NCAGE code (in lieu of a CAGE code) in order to register in SAM. eRA Commons - Applicants must have an active DUNS number to register in eRA Commons. Organizations can register with the eRA Commons as they are working through their SAM or Grants.
gov registration, but all registrations must be in place by time of submission. eRA Commons requires organizations to identify at least one Signing Official (SO) and at least one Program Director/Principal Investigator (PD/PI) account in order to submit an application. Grants.
gov Applicants must have an active DUNS number and SAM registration in order to complete the Grants. gov registration. Program Directors/Principal Investigators (PD(s)/PI(s)) All PD(s)/PI(s) must have an eRA Commons account.
PD(s)/PI(s) should work with their organizational officials to either create a new account or to affiliate their existing account with the applicant organization in eRA Commons. If the PD/PI is also the organizational Signing Official, they must have two distinct eRA Commons accounts, one for each role. Obtaining an eRA Commons account can take up to 2 weeks.
Eligible Individuals (Program Director/Principal Investigator) Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research administration and sustainability project as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support.
Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. For institutions/organizations proposing multiple PDs/PIs, visit the Multiple Program Director/Principal Investigator Policy and submission details in the Senior/Key Person Profile (Expanded) Component of the SF424 (R&R) Application Guide.
The PD/PI should be a senior institutional staff member with responsibility for grants administration (e.g. grants administrator, business official, or scientist with institutional grants management responsibilities). A doctorate degree is not required to be the PD/PI. This FOA does not require cost sharing as defined in the NIH Grants Policy Statement.
3. Additional Information on Eligibility Applicant organizations may submit more than one application, provided that each application is distinct. The NIH will not accept duplicate or highly overlapping applications under review at the same time.
This means that the NIH will not accept: A new (A0) application that is submitted before issuance of the summary statement from the review of an overlapping new (A0) or resubmission (A1) application. A resubmission (A1) application that is submitted before issuance of the summary statement from the review of the previous new (A0) application.
An application that has substantial overlap with another application pending appeal of initial peer review (see NOT-OD-11-101 ). Section IV. Application and Submission Information 1.
Requesting an Application Package The application forms package specific to this opportunity must be accessed through ASSIST, Grants. gov Workspace or an institutional system-to-system solution. Links to apply using ASSIST or Grants.
gov Workspace are available in Part 1 of this FOA. See your administrative office for instructions if you plan to use an institutional system-to-system solution. 2.
Content and Form of Application Submission It is critical that applicants follow the instructions in the Research (R) Instructions in the SF424 (R&R) Application Guide except where instructed in this funding opportunity announcement to do otherwise. Conformance to the requirements in the Application Guide is required and strictly enforced.
Applications that are out of compliance with these instructions may be delayed or not accepted for review. Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information that it contains allows IC staff to estimate the potential review workload and plan the review. By the date listed in Part 1.
Overview Information , prospective applicants are asked to submit a letter of intent that includes the following information: Descriptive title of proposed activity Name(s), address(es), and telephone number(s) of the PD(s)/PI(s) Names of other key personnel Participating institution(s) Number and title of this funding opportunity The letter of intent should be sent to: Louis A. Rosenthal, Ph. D.
National Institute of Allergy and Infectious Diseases (NIAID) All page limitations described in the SF424 Application Guide and the Table of Page Limits must be followed. Instructions for Application Submission Note: Effective for due dates on or after January 25, 2023 a Data Management and Sharing Plan is not applicable for this FOA.
The following section supplements the instructions found in the SF424 (R&R) Application Guide and should be used for preparing an application to this FOA. All instructions in the SF424 (R&R) Application Guide must be followed. SF424(R&R) Project/Performance Site Locations All instructions in the SF424 (R&R) Application Guide must be followed.
SF424(R&R) Other Project Information All instructions in the SF424 (R&R) Application Guide must be followed. SF424(R&R) Senior/Key Person Profile All instructions in the SF424 (R&R) Application Guide must be followed.
Include a biosketch for the PD/PI for this application indicating the individual's institutional responsibilities and authorities, as well as qualifications to serve as the senior administrator or scientist at the applicant institution. The PD/PI should be the person who travels to and receives training in the US.
If a multiple PD/PI application, the contact PD/PI will be the senior administrator at the LMIC and will be the person who travels to and receives training in the US. For the PD(s)/PI(s) a business degree or equivalent qualification is desirable, although not required.
Include a biosketch that indicates the expertise of any additional senior administrators requesting support to travel and receive training that demonstrates sufficient institutional responsibilities and authority to develop and implement strategies for strengthening the research administration and support mechanisms at their home institution as well as administrative and professional leadership qualities to enhance and implement the training/mentoring.
All instructions in the SF424 (R&R) Application Guide must be followed. Justification for the administrative, training or teaching responsibilities and time commitment for salaried foreign senior administrators. Justification for travel expenses for up to two foreign grants administrators including the PD/PI.
Justification for the consulting fees by the host US institution. Funds for US institutions will be limited to consultant fees at the host institution. Justification for the products/services needed for sustainability initiatives.
Applications requesting funds to promote distance learning including webinar training or videoconferencing may include $5,000 of direct costs. After 10 months of the project period, and submission of the program's progress to the program officer, up to $10,000 of direct cost may be used to support "sustainability initiatives". All instructions in the SF424 (R&R) Application Guide must be followed.
PHS 398 Cover Page Supplement All instructions in the SF424 (R&R) Application Guide must be followed.
All instructions in the SF424 (R&R) Application Guide must be followed, with the following additional instructions: Specific Aims : Briefly describe the specific aims of the proposed training program, including the overall goals, critical gaps in grants administration, objectives including the process for making sustainable business process changes, and how the program will meet the objectives outlined in this FOA.
Research Strategy: Applicants should describe their training strategy and implementation of related business processes and must include the following: Research Grants Administration/Financial Management Plan: Describe the ways that the administrators trained under this award will support faculty researchers performing NIAID funded research within the context of the research grant life cycle (receipt of award, budget implementation, and managing grant awards).
Describe the current grants administration/financial management process used at your institution. Identify which aspects of the grants administration-related services the proposed Research Grants Administration/Financial Management Plan will address (i.e., post-award expenditure tracking, financial reporting, or other NIH funding requirements) and explain how the current administration/plan will be improved.
Identify the US host and describe how the PD/PI and host administrators/business officials will interact to achieve the training and business practice goals of the program. Describe the overall strategy and methodology to be used to accomplish the specific aims and include a timeline.
Outline the processes and work tools that will be developed and/or acquired to address gaps in existing research grants administration support services (i.e., pre-award services, post-award services, compliance, preparation for Federal funding related audits etc.). Indicate how the proposed program of activities will be integrated into the institution's grants management functions.
Mentoring and development of junior grants management staff should be included in the application. The staff training plan should include a viable plan, based on allowable activities at the local institution, for senior grants management staff to train current and future institutional grants management leaders; essentially a "Train-the-Trainer" plan.
The staff training plan may also include grants management training opportunities or expertise that will be made available to other institutions that receive NIAID/NIH funding in the local area. For applicants that plan to provide training to other local in-country institutions, describe how this activity will be developed and executed.
Sustainability Initiative: Applicants should describe plans and procedures to develop and implement (including a timeline) grants management or related best business practices that could continue after the grant funding period ends.
Sustainability initiatives may include the development of a grants management training program at the college level to ensure a pipeline of grants management specialists, establishing an institutional sponsored research program office, or other activities that may result in sustainable changes. Applicants must describe the initiative, as well as how and when it will be implemented.
Describe the level of authority needed within the institute to implement and maintain grants management changes that result from the sustainability initiative. Indicate who has the authority and whether that person or entity has agreed to make changes, if needed.
Letters of Support: Applicants must provide the following letters of support: Letters of recommendation: Applicants must provide three letters of support from colleagues who have worked with the PD/PI and/or have the knowledge to describe and comment on his or her role in grants administration, effectiveness in working with a team and ability to successfully communicate and coordinate across organizational boundaries.
Each letter must also include the referee's name, title, institutional affiliation, address, telephone and fax numbers, and email address. Institutional Commitment Letter : A letter of commitment must be provided by the President or designated high-ranking official (i.e., Provost, Vice-President for Research, Dean, etc.) of the LMIC Institution as evidence of institutional commitment to enhancing research grants administration.
The letter should highlight the provision of adequate staff, facilities, authority to implement changes to the grants management process and resources that can contribute to the planned efforts to improve training in research grants administration. It should also include a commitment to the proposed sustainability initiative project described in the application.
In addition, the letter should affirm that the applicant institution has current NIAID funding and include the grant number(s) and total amount in U.S. dollars for all NIH grant and/or cooperative agreement support (direct awards) received in the last 5 years at the time of application submission.
US Institutional Commitment Letter : A letter of commitment must be provided by the business office of the US institution as evidence of institutional commitment to provide at least two grants management best practices training sessions at their institution.
It should also include a commitment to provide one senior grants manager with NIH grants management experience to oversee the two grants management training events, and to review the grantees proposed local grants management/business plans.
The letter should affirm that the US host institution, at the time of submission, has received at least $5 million per year in total NIH research grant and/or cooperative agreement support each year over the last 10 years. Resource Sharing Plan : Individuals are required to comply with the instructions for the Resource Sharing Plans as provided in the SF424 (R&R) Application Guide.
The following modifications also apply: Generally, Resource Sharing Plans are expected, but they are not applicable for this FOA. Only limited Appendix materials are allowed. Follow all instructions for the Appendix as described in the SF424 (R&R) Application Guide.
PHS Human Subjects and Clinical Trials Information When involving human subjects research, clinical research, and/or NIH-defined clinical trials (and when applicable, clinical trials research experience) follow all instructions for the PHS Human Subjects and Clinical Trials Information form in the SF424 (R&R) Application Guide, with the following additional instructions: If you answered Yes to the question Are Human Subjects Involved?
on the R&R Other Project Information form, you must include at least one human subjects study record using the Study Record: PHS Human Subjects and Clinical Trials Information form or Delayed Onset Study record. Study Record: PHS Human Subjects and Clinical Trials Information All instructions in the SF424 (R&R) Application Guide must be followed.
Note: Delayed onset does NOT apply to a study that can be described but will not start immediately (i.e., delayed start). All instructions in the SF424 (R&R) Application Guide must be followed. PHS Assignment Request Form All instructions in the SF424 (R&R) Application Guide must be followed.
Foreign (non-U.S.) institutions must follow policies described in the NIH Grants Policy Statement , and procedures for foreign institutions described throughout the SF424 (R&R) Application Guide. 3. Unique Entity Identifier and System for Award Management (SAM) See Part 1.
Section III. 1 for information regarding the requirement for obtaining a unique entity identifier and for completing and maintaining active registrations in System for Award Management (SAM), NATO Commercial and Government Entity (NCAGE) Code (if applicable), eRA Commons, and Grants. gov. 4.
Submission Dates and Times Part I. Overview Information contains information about Key Dates and times. Applicants are encouraged to submit applications before the due date to ensure they have time to make any application corrections that might be necessary for successful submission.
When a submission date falls on a weekend or Federal holiday , the application deadline is automatically extended to the next business day. Organizations must submit applications to Grants. gov (the online portal to find and apply for grants across all Federal agencies).
Applicants must then complete the submission process by tracking the status of the application in the eRA Commons , NIH’s electronic system for grants administration. NIH and Grants. gov systems check the application against many of the application instructions upon submission.
Errors must be corrected and a changed/corrected application must be submitted to Grants. gov on or before the application due date and time. If a Changed/Corrected application is submitted after the deadline, the application will be considered late.
Applications that miss the due date and time are subjected to the NIH Policy on Late Application Submission. Applicants are responsible for viewing their application before the due date in the eRA Commons to ensure accurate and successful submission. Information on the submission process and a definition of on-time submission are provided in the SF424 (R&R) Application Guide.
5. Intergovernmental Review (E. O.
12372) This initiative is not subject to intergovernmental review. All NIH awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement . Pre-award costs are allowable only as described in the NIH Grants Policy Statement .
7. Other Submission Requirements and Information Applications must be submitted electronically following the instructions described in the SF424 (R&R) Application Guide. Paper applications will not be accepted.
Applicants must complete all required registrations before the application due date. Section III. Eligibility Information contains information about registration.
For assistance with your electronic application or for more information on the electronic submission process, visit How to Apply Application Guide . If you encounter a system issue beyond your control that threatens your ability to complete the submission process on-time, you must follow the Dealing with System Issues guidance. For assistance with application submission, contact the Application Submission Contacts in Section VII .
All PD(s)/PI(s) must include their eRA Commons ID in the Credential field of the Senior/Key Person Profile Component of the SF424(R&R) Application Package. Failure to register in the Commons and to include a valid PD/PI Commons ID in the credential field will prevent the successful submission of an electronic application to NIH. See Section III of this FOA for information on registration requirements.
The applicant organization must ensure that the DUNS number it provides on the application is the same number used in the organization’s profile in the eRA Commons and for the System for Award Management. Additional information may be found in the SF424 (R&R) Application Guide. See more tips for avoiding common errors.
Upon receipt, applications will be evaluated for completeness and compliance with application instructions by the Center for Scientific Review, NIH. Applications that are incomplete or non-compliant will not be reviewed. Post Submission Materials Applicants are required to follow the instructions for post-submission materials, as described in the policy .
Any instructions provided here are in addition to the instructions in the policy. Section V. Application Review Information Only the review criteria described below will be considered in the review process.
Applications submitted to the NIH in support of the NIH mission are evaluated for scientific and technical merit through the NIH peer review system.
Reviewers will provide an overall impact score to reflect their assessment of the likelihood for the project to exert a sustained, powerful influence on the research field(s) involved, in consideration of the following review criteria and additional review criteria (as applicable for the project proposed).
Reviewers will consider each of the review criteria below in the determination of scientific merit, and give a separate score for each. An application does not need to be strong in all categories to be judged likely to have major scientific impact. For example, a project that by its nature is not innovative may be essential to advance a field.
Does the project address an important grants management or oversight problem or a critical barrier to progress in the field? If the aims of the project are achieved, how will knowledge, technical capability, and/or grants administration practices be improved? How will successful completion of the aims change the concepts, methods, technologies, treatments, services, or preventative interventions that drive this field?
Is the proposed project well justified in terms of addressing deficiencies or gaps in the existing research grants administration/financial management infrastructure? Are processes and/or work tools identified that need to be developed, facilitated, or acquired to address current gaps in the infrastructure?
Does the staff training plan facilitate the strengthening of grants administration at the grantee institution and, where proposed, other in-country institutions? Are the PD(s)/PI(s), collaborators, and other research administrators (or researcher with significant grants administration responsibilities) well suited to the project? If established, have they demonstrated an
According to the current listing, eligibility includes: Non-domestic (non-U. S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U. S.) components of U. S. Organizations are eligible to apply. Confirm the full requirements in the official notice before applying.
The current listing shows application budgets are limited to $94,000 direct costs per year exclusive of consortium indirect costs. The maximum project period is 3 years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was August 6, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed) is funded by NIH Fogarty International Center. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article